- Home
- EDSA vs IMCC Comparison
EDSA vs IMCC Comparison
Compare EDSA & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- IMCC
- Stock Information
- Founded
- EDSA 2015
- IMCC 1980
- Country
- EDSA Canada
- IMCC Israel
- Employees
- EDSA N/A
- IMCC N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- EDSA Health Care
- IMCC Health Care
- Exchange
- EDSA Nasdaq
- IMCC Nasdaq
- Market Cap
- EDSA 6.2M
- IMCC 5.3M
- IPO Year
- EDSA N/A
- IMCC N/A
- Fundamental
- Price
- EDSA $1.83
- IMCC $2.76
- Analyst Decision
- EDSA Strong Buy
- IMCC
- Analyst Count
- EDSA 1
- IMCC 0
- Target Price
- EDSA $21.00
- IMCC N/A
- AVG Volume (30 Days)
- EDSA 35.8K
- IMCC 631.6K
- Earning Date
- EDSA 05-14-2025
- IMCC 05-15-2025
- Dividend Yield
- EDSA N/A
- IMCC N/A
- EPS Growth
- EDSA N/A
- IMCC N/A
- EPS
- EDSA N/A
- IMCC N/A
- Revenue
- EDSA N/A
- IMCC $37,894,737.00
- Revenue This Year
- EDSA N/A
- IMCC $47.12
- Revenue Next Year
- EDSA N/A
- IMCC $12.83
- P/E Ratio
- EDSA N/A
- IMCC N/A
- Revenue Growth
- EDSA N/A
- IMCC 12.68
- 52 Week Low
- EDSA $1.55
- IMCC $1.29
- 52 Week High
- EDSA $5.59
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- EDSA 29.28
- IMCC 52.50
- Support Level
- EDSA $1.88
- IMCC $2.55
- Resistance Level
- EDSA $2.05
- IMCC $7.12
- Average True Range (ATR)
- EDSA 0.08
- IMCC 1.08
- MACD
- EDSA -0.00
- IMCC 0.01
- Stochastic Oscillator
- EDSA 0.00
- IMCC 21.85
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.